4Front Ventures Corp. (FFNTF) Financial Statements (2025 and earlier)

Company Profile

Business Address 7010 E. CHAUNCEY LANE STE. 235
PHOENIX, AZ 85054
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,4242,8893,3982,7655,4004,600
Cash and cash equivalent2,4242,8893,3982,7655,4004,600
Receivables6,6364,8644,4174,43010,3868,683
Inventory, net of allowances, customer advances and progress billings17,56316,37717,08717,16225,36527,388
Inventory17,56316,37717,08717,16225,36527,388
Disposal group, including discontinued operation1,7991,5801,6962,918  
Other undisclosed current assets7,6397,2217,3146,4816,2925,397
Total current assets:36,06132,93133,91233,75647,44346,068
Noncurrent Assets
Operating lease, right-of-use asset132,301117,626118,511120,219135,577137,002
Property, plant and equipment37,59637,46136,54939,28655,48255,382
Intangible assets, net (including goodwill)67,63868,11568,60069,15883,45784,184
Goodwill41,80741,80741,80741,80753,92653,955
Intangible assets, net (excluding goodwill)25,83126,30826,79327,35129,53130,229
Deposits noncurrent assets2,5032,4192,4192,4193,6965,868
Other undisclosed noncurrent assets2,8913,4443,9634,4364,8515,242
Total noncurrent assets:242,929229,065230,042235,518283,063287,678
TOTAL ASSETS:278,990261,996263,954269,274330,506333,746
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities55,35154,19451,04950,84455,91851,224
Accounts payable13,26113,90711,41512,30514,72412,048
Accrued liabilities42,09040,28739,63438,53941,19439,176
Deferred revenue     639682
Debt16,82416,32025,630   
Derivative instruments and hedges, liabilities5,4786,3454,55016,096  
Disposal group, including discontinued operation11,92712,00912,03711,807  
Other undisclosed current liabilities23,88020,31710,73419,19624,65323,122
Total current liabilities:113,460109,185104,00097,94381,21075,028
Noncurrent Liabilities
Long-term debt and lease obligation27,33527,19358,54342,58542,14241,721
Long-term debt, excluding current maturities27,33527,19358,54342,58542,14241,721
Liabilities, other than long-term debt151,317136,105135,828131,534147,144147,527
Deferred revenue     2,0002,000
Deferred income tax liabilities11,88211,88211,8827,2937,6148,024
Operating lease, liability139,435124,223123,946124,241137,530137,503
Other undisclosed noncurrent liabilities31,41630,08216,97747,80452,18451,491
Total noncurrent liabilities:210,068193,380211,348221,923241,470240,739
Total liabilities:323,528302,565315,348319,866322,680315,767
Equity
Equity, attributable to parent, including:(44,646)(40,677)(51,502)(50,700)7,72317,881
Additional paid in capital68,85467,95666,94863,46160,64560,431
Accumulated deficit(450,722)(445,855)(427,402)(420,722)(358,621)(347,152)
Other undisclosed equity, attributable to parent337,222337,222308,952306,561305,699304,602
Equity, attributable to noncontrolling interest10810810810810398
Total equity:(44,538)(40,569)(51,394)(50,592)7,82617,979
TOTAL LIABILITIES AND EQUITY:278,990261,996263,954269,274330,506333,746

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues18,65618,84220,97923,00230,69630,376
Cost of revenue
(Cost of Product and Service Sold)
(11,317)(11,268)(12,659)(13,722)(21,100)(19,388)
Gross profit:7,3397,5748,3209,2809,59610,988
Operating expenses(11,729)(12,345)(14,698)(23,419)(15,378)(16,784)
Operating loss:(4,390)(4,771)(6,378)(14,139)(5,782)(5,796)
Nonoperating income (expense)(852)(13,577)7,497(16,488)(656)669
Investment income, nonoperating86775811,706(12,091)714
Other nonoperating income (expense)(22)(99)152(1,054)(663)655
Interest and debt expense(1,702)(11,752)9,590(3,322)(3,075)(3,196)
Income (loss) from continuing operations before equity method investments, income taxes:(6,944)(30,100)10,709(33,949)(9,513)(8,323)
Other undisclosed income (loss) from continuing operations before income taxes1,70211,752(9,590)3,322 (3)
Income (loss) from continuing operations before income taxes:(5,242)(18,348)1,119(30,627)(9,513)(8,326)
Income tax expense (benefit)   (6,274)4,199(1,951)(3,066)
Loss from continuing operations:(5,242)(18,348)(5,155)(26,428)(11,464)(11,392)
Income (loss) from discontinued operations375(105)(1,525)(35,668)  
Net loss:(4,867)(18,453)(6,680)(62,096)(11,464)(11,392)
Net loss attributable to noncontrolling interest    (5)(5)(5)
Net loss available to common stockholders, diluted:(4,867)(18,453)(6,680)(62,101)(11,469)(11,397)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net loss:(4,867)(18,453)(6,680)(62,096)(11,464)(11,392)
Comprehensive loss:(4,867)(18,453)(6,680)(62,096)(11,464)(11,392)
Comprehensive loss, net of tax, attributable to noncontrolling interest    (5)(5)(5)
Comprehensive loss, net of tax, attributable to parent:(4,867)(18,453)(6,680)(62,101)(11,469)(11,397)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: